» Articles » PMID: 10674666

Application of Molecular Typing Techniques in the 1998 Dengue Epidemic in Nicaragua

Overview
Specialty Tropical Medicine
Date 2000 Feb 16
PMID 10674666
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

This report presents the results of applying the reverse transcriptase-polymerase chain reaction (RT-PCR) to the analysis of clinical specimens during the 1998 dengue epidemic in Nicaragua. The RT-PCR was validated through comparison with viral isolation, resulting in a sensitivity of 100% and a specificity of 90%. In-country application of the RT-PCR permitted the rapid identification of dengue-3 virus as the cause of the epidemic at the beginning of 1998 and the detection of the reintroduction of dengue-2 virus in the middle of the year. Nineteen isolates of dengue-3 and one of dengue-2 were characterized using the restriction site-specific (RSS)-PCR technique. This showed that the dengue-3 strain belonged to the "Sri Lanka" subtype and that the dengue-2 strain belonged to the "Jamaica" subtype, both of which have been associated with hemorrhagic dengue in the Americas. The application of these simple PCR-based strain typing methods in a country endemic for dengue virus infections can help to characterize the transmission dynamics of this important emerging infectious disease problem and provide this information to local health authorities in a timely manner so that appropriate control measures can be implemented.

Citing Articles

Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua.

Narvaez F, Montenegro C, Juarez J, Zambrana J, Gonzalez K, Videa E PLoS Negl Trop Dis. 2025; 19(1):e0012811.

PMID: 39792951 PMC: 11750095. DOI: 10.1371/journal.pntd.0012811.


Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease.

Dias Jr A, Duarte E, Zambrana J, Cardona-Ospina J, Bos S, Roy V medRxiv. 2024; .

PMID: 38883768 PMC: 11177908. DOI: 10.1101/2024.06.03.24308395.


Introduction of New Dengue Virus Lineages of Multiple Serotypes after COVID-19 Pandemic, Nicaragua, 2022.

Cerpas C, Vasquez G, Moreira H, Juarez J, Coloma J, Harris E Emerg Infect Dis. 2024; 30(6):1203-1213.

PMID: 38782023 PMC: 11138998. DOI: 10.3201/eid3006.231553.


Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype.

Bos S, Graber A, Cardona-Ospina J, Duarte E, Zambrana J, Ruiz Salinas J Nat Commun. 2024; 15(1):382.

PMID: 38195666 PMC: 10776616. DOI: 10.1038/s41467-023-44330-8.


Primary exposure to Zika virus increases risk of symptomatic dengue virus infection with serotypes 2, 3, and 4 but not serotype 1.

Zambrana J, Hasund C, Aogo R, Bos S, Arguello S, Gonzalez K medRxiv. 2023; .

PMID: 38077039 PMC: 10705633. DOI: 10.1101/2023.11.29.23299187.